COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 38 filers reported holding COMPASS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,088,156 | -33.6% | 6,660,638 | +7.1% | 0.01% | -25.0% |
| Q2 2023 | $19,713,413 | +0.5% | 6,218,741 | +3.6% | 0.01% | -7.7% |
| Q1 2023 | $19,616,292 | -34.2% | 6,004,473 | +1.1% | 0.01% | -38.1% |
| Q4 2022 | $29,802,571 | +269.0% | 5,939,290 | -15.7% | 0.02% | +250.0% |
| Q3 2022 | $8,076,068 | -8.3% | 7,045,960 | +110.5% | 0.01% | 0.0% |
| Q2 2022 | $8,803,000 | +103.4% | 3,347,171 | +4.8% | 0.01% | +200.0% |
| Q1 2022 | $4,327,000 | -7.9% | 3,193,294 | +116.8% | 0.00% | 0.0% |
| Q4 2021 | $4,698,000 | – | 1,472,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,246,977 | $2,456,545 | 3.92% |
| CHI Advisors LLC | 2,829,712 | $5,574,532 | 2.21% |
| Ally Bridge Group (NY) LLC | 914,630 | $1,801,821 | 2.12% |
| Monashee Investment Management LLC | 1,226,142 | $2,415,500 | 1.01% |
| Orbimed Advisors | 22,362,850 | $44,054,815 | 0.94% |
| Vivo Capital, LLC | 3,556,023 | $7,005,365 | 0.77% |
| CAXTON CORP | 86,773 | $170,942 | 0.65% |
| Prosight Management, LP | 935,157 | $1,842,259 | 0.58% |
| BRAIDWELL LP | 5,954,273 | $11,729,918 | 0.37% |
| Rock Springs Capital Management LP | 5,513,788 | $10,862,162 | 0.29% |